Biocompatibles disappointed investors by reporting an operating loss of 9 million pounds (e14.4m-$13.1m) for the 1st half of this year, in spite of a 38 percent sales increase to £32 million (e 51.3m-$46.5m), but the company said results would improve in the 2nd half and reach the break-even level in ...
Buying a membership today will give you:
To continue reading this article register now.